
In this episode of Talks at GS, Dr. Michael Mina of the Harvard T.H. Chan School of Public Health discusses the evolving understanding of COVID-19 biology and epidemiology and approaches to “flatten the curve” in the context of diagnostics, potential therapeutics and vaccines.
Our weekly newsletter delivers the latest insights on economic forces shaping markets—from Goldman Sachs leaders, economists, and investors around the world.
You can unsubscribe at any time. For information about how your personal data will be used, visit Privacy Information and Resources.